Wall Street Analyst Alerts: Dow Chemical, Micron Tech, Allergan, Core Labs
The Dow Chemical Company (NYSE:DOW): Dow Chemical mentioned cautiously at JP Morgan.
Micron Technology Inc.(NASDAQ:MU): Pacific Crest views planned capex reductions at both Elpida and Hynix as a positive for Micron and the DRAM industry.
Allergan Inc.(NYSE:AGN): Leerink defends shares of Allergan amid today’s sell-off following the company’s results. The firm has an Outperform rating on the stock.
Core Laboratories NV(NYSE:CLB): Pritchard raised its price target and says Core Laboratories continues to be one of its top picks following the company’s Q4 results.
Dynavax Technologies Corporation(NASDAQ:DVAX): William Blair views the FDA approval of an expanded Heplisav label as a significant positive development for Dynavax. The firm believes the move signals that the FDA is positive on Heplisav’s safety profile and novel adjuvants, making it highly likely the drug will be approved at first pass.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.
To contact the reporter on this story: Derek Hoffman at firstname.lastname@example.org
To contact the editor responsible for this story: Damien Hoffman at email@example.com